ESB
Essex Savings Bank’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Sell |
1,677
-88
| -5% | -$35.7K | 0.16% | 122 |
|
|
2025
Q1 | $878K | Buy |
1,765
+17
| +1% | +$8.46K | 0.22% | 99 |
|
|
2024
Q4 | $909K | Buy |
1,748
+45
| +3% | +$23.4K | 0.23% | 92 |
|
|
2024
Q3 | $1.05M | Buy |
1,703
+162
| +11% | +$100K | 0.26% | 88 |
|
|
2024
Q2 | $852K | Buy |
1,541
+7
| +0.5% | +$3.87K | 0.23% | 94 |
|
|
2024
Q1 | $814K | Hold |
1,534
| – | – | 0.24% | 102 |
|
|
2023
Q4 | $814K | Buy |
1,534
+56
| +4% | +$29.7K | 0.24% | 102 |
|
|
2023
Q3 | $748K | Sell |
1,478
-25
| -2% | -$12.7K | 0.25% | 88 |
|
|
2023
Q2 | $784K | Sell |
1,503
-27
| -2% | -$14.1K | 0.26% | 86 |
|
|
2023
Q1 | $882K | Sell |
1,530
-96
| -6% | -$55.3K | 0.31% | 78 |
|
|
2022
Q4 | $895K | Sell |
1,626
-52
| -3% | -$28.6K | 0.32% | 74 |
|
|
2022
Q3 | $851K | Sell |
1,678
-1
| -0.1% | -$507 | 0.34% | 72 |
|
|
2022
Q2 | $912K | Sell |
1,679
-54
| -3% | -$29.3K | 0.35% | 74 |
|
|
2022
Q1 | $1.02M | Sell |
1,733
-118
| -6% | -$69.7K | 0.34% | 73 |
|
|
2021
Q4 | $1.24M | Buy |
1,851
+129
| +7% | +$86.1K | 0.42% | 58 |
|
|
2021
Q3 | $955K | Sell |
1,722
-20
| -1% | -$11.1K | 0.35% | 80 |
|
|
2021
Q2 | $818K | Buy |
1,742
+170
| +11% | +$79.8K | 0.32% | 85 |
|
|
2021
Q1 | $707K | Buy |
1,572
+13
| +0.8% | +$5.85K | 0.31% | 84 |
|
|
2020
Q4 | $726K | Sell |
1,559
-632
| -29% | -$294K | 0.32% | 83 |
|
|
2020
Q3 | $968K | Sell |
2,191
-60
| -3% | -$26.5K | 0.47% | 56 |
|
|
2020
Q2 | $816K | Sell |
2,251
-13
| -0.6% | -$4.71K | 0.48% | 53 |
|
|
2020
Q1 | $642K | Buy |
2,264
+343
| +18% | +$97.3K | 0.46% | 60 |
|
|
2019
Q4 | $624K | Sell |
1,921
-141
| -7% | -$45.8K | 0.32% | 81 |
|
|
2019
Q3 | $600K | Sell |
2,062
-925
| -31% | -$269K | 0.32% | 80 |
|
|
2019
Q2 | $877K | Buy |
2,987
+312
| +12% | +$91.6K | 0.31% | 70 |
|
|
2019
Q1 | $732K | Sell |
2,675
-50
| -2% | -$13.7K | 0.42% | 55 |
|
|
2018
Q4 | $610K | Buy |
+2,725
| New | +$610K | 0.38% | 64 |
|